0001790340-24-000002.txt : 20240102
0001790340-24-000002.hdr.sgml : 20240102
20240102162606
ACCESSION NUMBER: 0001790340-24-000002
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240101
FILED AS OF DATE: 20240102
DATE AS OF CHANGE: 20240102
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Feinberg Peter
CENTRAL INDEX KEY: 0001870076
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-40675
FILM NUMBER: 24502790
MAIL ADDRESS:
STREET 1: C/O IMMUNEERING CORPORATION
STREET 2: 245 MAIN STREET, SECOND FLOOR
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Immuneering Corp
CENTRAL INDEX KEY: 0001790340
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 245 MAIN STREET, SECOND FLOOR
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
BUSINESS PHONE: 617-500-8080
MAIL ADDRESS:
STREET 1: 245 MAIN STREET, SECOND FLOOR
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
4
1
wk-form4_1704230750.xml
FORM 4
X0508
4
2024-01-01
0
0001790340
Immuneering Corp
IMRX
0001870076
Feinberg Peter
245 MAIN STREET
SECOND FLOOR
CAMBRIDGE
MA
02142
1
0
0
0
0
Stock Option
7.35
2024-01-01
4
A
0
6879
0
A
2034-01-01
Class A Common Stock
6879
6879
D
Pursuant to the Immuneering Corporation Non-Employee Director Compensation Program (the "Compensation Program"), the reporting person elected to receive this stock option in lieu of receiving the cash Base Retainer (as defined in the Compensation Program).
The option vests and becomes exercisable as to 25% of the shares subject to the option upon the reporting person completing three months of continuous service as a Non-Employee Director (as defined in the Compensation Program) following the grant date, such that the fourth and final installment will vest and become exercisable on the first anniversary of the grant date, subject in each case to such continuous service.
By: /s/ Michael D. Bookman, Attorney-in-Fact for Peter Feinberg
2024-01-02